HPR130 Analysis of Forty-One Years of U.S. Food and Drug Administration Approvals, Regulatory Pathways, and Review Time of New Drugs and Biologics: A Retrospective Cohort Study
Abstract
Authors
E Seoane-Vazquez R Rodriguez-Monguio JH Powers